Great to see AGEAN regime approved and reimbursed in England. You know we really are lucky to have this option alongside CM816 & KN671, without PD-L1 restriction
Reposted from
BTOG
NEW NICE APPROVAL published today. NICE has appraised durvalumab within its marketing authorisation, as neoadjuvant treatment with platinum-based chemotherapy ... (continued) #LCSM #lungcancer
Comments